Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
85.00
Ask:
100.00
Spread: 15.00 (17.647%)
Market Cap: £13.28m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Further re Totility acquisition

11 Jul 2012 07:00

RNS Number : 3739H
Maintel Holdings PLC
11 July 2012
 

11 July 2012

Maintel Holdings Plc

("Maintel" or "the Company")

 

Agreement of balance of Totility consideration

 

 

On 30 September 2011, Maintel announced the acquisition of Totility Limited ("Totility") ("Acquisition") for an initial consideration of £2.8m. As disclosed in the announcement, the sale and purchase agreement signed by the Company in relation to the acquisition of Totility provided for the payment to the vendors of additional consideration of up to £4 million dependent on the profitability of Totility in the 12 month period following its acquisition.

 

In order to allow greater flexibility in Totility's commercial and operational dealings outside of the parameters set by the sale and purchase agreement, the Board is of the view that an advance agreement of the amount due in respect of this additional consideration is in the best interests of the Company. The Board has therefore agreed with the vendors a total additional consideration payment of £3.1m, £0.9m less than the maximum amount payable, of which £2.2m will be paid on 31 October 2012 and £0.9m on 3 January 2013.

 

These amounts are in addition to the previously announced further consideration payable to the Totility shareholders representing the net asset value of Totility as at the date of the Acquisition. This amounted to £986,000. Separately, a further payment of £100,000 was made on 10 July 2012 to the vendors under the terms of the sale and purchase agreement. As a result, the total consideration payable for the Acquisition will be £7.0m including the net assets.

 

Terence McKeever, one of the founders and vendors of Totility, will continue to be employed until 20 October 2012, following which he will provide consultancy services to Maintel and Totility until 28 February 2013.

 

 

 

 

 

Enquiries:

Maintel

Eddie Buxton - Chief Executive 020 7401 4601

Dale Todd - Finance Director 020 7401 0562

 

FinnCap

Marc Young/Charlotte Stranner 020 7220 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURURRBRUAABAAR
Date   Source Headline
3rd Jun 20267:00 amRNSNotice of AGM
1st Jun 20264:44 pmRNSResult of General Meeting
29th May 20262:03 pmRNSResult of Retail Offer and Update on Timing
13th May 20262:35 pmRNSRetail Offer
13th May 20262:30 pmRNSPlacing and Issue of Convertible Loan Notes
11th Feb 20263:26 pmRNSWithdrawal of Requisition
27th Jan 20267:00 amRNSRequisition of General Meeting
22nd Jan 20267:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNS-RNotice of Investor Presentation
3rd Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAppointment of Non-Executive Chair
6th Aug 20257:00 amRNS-RAppointment of Chief Operating Officer
29th Jul 20257:00 amRNSTrading Update and Notice of Results
3rd Jun 20255:32 pmRNSResult of Annual General Meeting
3rd Jun 20257:00 amRNSAGM Trading Update
15th May 20257:00 amRNS-RYellowstone Advisory Private Investor Evening
12th May 20257:00 amRNSGrant of Options
8th May 20254:47 pmRNSAnnual Report and Notice of AGM
6th May 20257:00 amRNS2024 Annual Audited Results
2nd May 20257:00 amRNS-RNotice of Investor Presentation
1st May 20257:00 amRNSNotice of Annual Results
22nd Apr 20257:00 amRNSChange of Registered Office
25th Feb 20257:00 amRNSAppointment of Chief Executive Officer
31st Jan 20257:00 amRNSTrading Update
19th Sep 20247:00 amRNSInterim Results
7th Aug 20247:00 amRNSTrading Update and Notice of Results
3rd Jul 20247:00 amRNSAppointment of Non-Executive Directors
19th Jun 20242:24 pmRNSResult of AGM
19th Jun 20247:00 amRNSAGM Trading Update
10th May 20245:02 pmRNSAnnual Report and Notice of AGM
3rd May 202410:01 amRNSPublication of Annual Report
1st May 20247:00 amRNSFinal Results
18th Apr 202412:30 pmRNSBoard Changes
18th Apr 20247:00 amRNSNotice of Final Results
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSBoard Changes
22nd Jan 20247:00 amRNSTrading Update and Notice of Results
16th Oct 20234:15 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSDirector/PDMR Shareholding
19th Sep 20231:34 pmRNSReplacement: Interim results
19th Sep 20237:00 amRNSInterim results
4th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading update and Notice of Results
30th May 20235:25 pmRNSResults of AGM and Board Changes
30th May 20231:03 pmRNSAGM Statement
11th May 20232:20 pmRNSDirector Appointment
4th May 20235:15 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSGrant and Surrender of Options
27th Apr 20237:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.